Community-acquired respiratory virus infections in patients with haematological malignancies or undergoing haematopoietic cell transplantation: updated recommendations from the 10th ECIL-Guidelines- The Lancet Infectious Diseases https://t.co/RDJDcHk1NK
Deep B cell depletion is rebooting the immune system, the basis for a potential curative approach to a long list of autoimmune diseases
https://t.co/yIJCikSNe5
How does the ISBT 128 Standard support cross-border traceability and patient safety across Europe? 🌍Read our latest blog to learn more.
🔗 https://t.co/GSFKQTcbP1
#ICCBBA#ISBT128Standard#Traceability#PatientSafety
Today in Dubrovnik at 8th International Chronic Graft-versus-Host Disease Symposium sharing the results of our Belumosudil analysis 🇮🇹 🇪🇸 🇬🇧 #cGvHD#HSTC
HLA matching did not affect late transplantation outcomes after PT-Cy–based GVHD prophylaxis. Older donor age and female-to-male donor-recipient sex mismatch were associated with increased late NRM. Read in Blood Neoplasia: https://t.co/3zdPo31UcS
Validation and refinement of the new Consensus Genomic Staging (CGS) of high-risk multiple myeloma (HRMM) in relapsed and refractory patients treated with BCMA CAR-T. | Blood Cancer Journal https://t.co/evyALLAP1q
Super excited to share our How-I-Treat our today in @BloodPortfolio where we show how we integrate somatic mutations and other alterations 🧬 into the diagnosis and clinical care of #BMFsm patients. @fergutierrezro1@bhavishap29@NIH https://t.co/CnSeDfvc7E
What should be the optimal strategy after AZA–VEN–induced remission in younger AML patients not proceeding to allo-HSCT?
Our recent work explores this clinically relevant question.
Read more in @BloodCancerJnl : 👉https://t.co/D2qYE1Vjbm
Grateful to @ArihantDr, @DrGPrakash, and @DrPMPGI Sir, for their invaluable support and conceptual guidance.
@AML_Hub #leusm #Hematology @blood_academy@SOAsocialmedia@ims_sum
Finalizamos nuestro curso de Enfermería en CART con invitada de lujo @mercedesmontoro@hospitalclinic y una concurrencia excepcional presencial y virtual 👏👏 @Carlitocha Gracias a todos por acompañarnos
Efficacy of Low-Dose Olanzapine for the Prevention of Conditioning Therapy-Induced Nausea and Vomiting in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
https://t.co/UnyiQRPljU
Thrilled to share this collaborative work from GATMO-TC exploring whether HLA-haploidentical related donors may represent a donor choice for patients with severe aplastic anemia. A true multicenter effort from Argentina.
https://t.co/d25O8YA9mE